Metabolism and permeability of curcumin in cultured Caco-2 cells

被引:81
作者
Dempe, Julia S. [1 ]
Scheerle, Romy K. [1 ]
Pfeiffer, Erika [1 ]
Metzler, Manfred [1 ]
机构
[1] Karlsruhe Inst Technol, Chair Food Chem, Inst Appl Biosci, D-76131 Karlsruhe, Germany
关键词
Caco-2; cells; Curcumin; Hexahydrocurcumin; Metabolism; Permeability; CHEMOPREVENTIVE AGENT; INTESTINAL-ABSORPTION; IN-VITRO; STABILITY; TISSUE;
D O I
10.1002/mnfr.201200113
中图分类号
TS2 [食品工业];
学科分类号
100403 [营养与食品卫生学];
摘要
Scope Curcumin(CUR) and its major metabolite hexahydro-CUR were studied in Caco-2 cells and in the Caco-2 Millicell (R) system in vitro to simulate their in vivo intestinal metabolism and absorption in humans. Methods and resultsAnalysis of the incubation medium and cell lysate showed that Caco-2 cells reduce CUR to hexahydro-CUR and octahydro-CUR, and conjugate CUR and its reductive metabolites with glucuronic acid and sulfate. Using the Caco-2 Millicell (R) system, an efficient transfer of the conjugates into the basolateral, but not the apical, compartment was observed after apical administration. Likewise, hexahydro-CUR was reduced to octahydro-CUR, and glucuronide and sulfate conjugates almost exclusively permeated to the basolateral side. The apparent permeability coefficients (P-app values) of CUR, hexahydro-CUR and their metabolites were determined and found to be extremely low for unchanged CUR, but somewhat higher for hexahydro-CUR and the conjugated metabolites. ConclusionThe results of this study clearly show that the systemic bioavailability of CUR from the intestine after oral intake must be expected to be virtually zero. Reductive and conjugated metabolites, formed from CUR in the intestine, exhibit moderate absorption. Thus, any biological effects elicited by CUR in tissues other than the gastrointestinal tract are likely due to CUR metabolites.
引用
收藏
页码:1543 / 1549
页数:7
相关论文
共 23 条
[1]
Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1
[2]
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature [J].
Anand, Preetha ;
Thomas, Sherin G. ;
Kunnumakkara, Ajaikumar B. ;
Sundaram, Chitra ;
Harikumar, Kuzhuvelil B. ;
Sung, Bokyung ;
Tharakan, Sheeja T. ;
Misra, Krishna ;
Priyadarsini, Indira K. ;
Rajasekharan, Kallikat N. ;
Aggarwal, Bharat B. .
BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) :1590-1611
[3]
Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[4]
[Anonymous], 2000, GUID IND WAIV IN VIV
[5]
CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
KARLSSON, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) :880-885
[6]
Cheng AL, 2001, ANTICANCER RES, V21, P2895
[7]
Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells [J].
Dempe, Julia S. ;
Pfeiffer, Erika ;
Grimm, Anne S. ;
Metzler, Manfred .
MOLECULAR NUTRITION & FOOD RESEARCH, 2008, 52 (09) :1074-1081
[8]
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration [J].
Garcea, G ;
Jones, DJL ;
Singh, R ;
Dennison, AR ;
Farmer, PB ;
Sharma, RA ;
Steward, WP ;
Gescher, AJ ;
Berry, DP .
BRITISH JOURNAL OF CANCER, 2004, 90 (05) :1011-1015
[9]
Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver [J].
Hoehle, SI ;
Pfeiffer, E ;
Sólyom, AM ;
Metzler, M .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2006, 54 (03) :756-764
[10]
Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105